276 related articles for article (PubMed ID: 30375086)
1. Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database.
Anzai T; Takahashi K; Watanabe M
Psychiatry Clin Neurosci; 2019 Jan; 73(1):27-33. PubMed ID: 30375086
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.
Trollor JN; Chen X; Sachdev PS
CNS Drugs; 2009; 23(6):477-92. PubMed ID: 19480467
[TBL] [Abstract][Full Text] [Related]
3. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
Reeves RR; Mack JE; Torres RA
Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome induced by atypical antipsychotics.
Farver DK
Expert Opin Drug Saf; 2003 Jan; 2(1):21-35. PubMed ID: 12904122
[TBL] [Abstract][Full Text] [Related]
7. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database.
Nakamura M; Yasunaga H; Miyata H; Shimada T; Horiguchi H; Matsuda S
J Clin Psychiatry; 2012 Apr; 73(4):427-30. PubMed ID: 22154901
[TBL] [Abstract][Full Text] [Related]
8. Risperidone-induced neuroleptic malignant syndrome.
Sharma R; Trappler B; Ng YK; Leeman CP
Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan.
Misawa F; Okumura Y; Takeuchi Y; Fujii Y; Takeuchi H
Schizophr Res; 2021 May; 231():42-46. PubMed ID: 33752105
[TBL] [Abstract][Full Text] [Related]
10. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
11. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
Meterissian GB
Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics.
Trollor JN; Chen X; Chitty K; Sachdev PS
Br J Psychiatry; 2012 Jul; 201(1):52-6. PubMed ID: 22626633
[TBL] [Abstract][Full Text] [Related]
13. The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome.
Kyotani Y; Zhao J; Nakahira K; Yoshizumi M
Sci Rep; 2023 Oct; 13(1):18459. PubMed ID: 37891209
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
Bellamy CJ; Kane-Gill SL; Falcione BA; Seybert AL
J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Expression Profile of Extrapyramidal Symptoms Due to Antipsychotics by Data Mining of Japanese Adverse Drug Event Report (JADER) Database.
Kose E; Uno K; Hayashi H
Yakugaku Zasshi; 2017; 137(1):111-120. PubMed ID: 28049887
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Sokoro AA; Zivot J; Ariano RE
Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature.
Seitz DP; Gill SS
Psychosomatics; 2009; 50(1):8-15. PubMed ID: 19213967
[TBL] [Abstract][Full Text] [Related]
18. What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review.
Virolle J; Redon M; Montastruc F; Taïb S; Revet A; Zivkovic V; Da Costa J; Very E
Schizophr Res; 2023 Dec; 262():184-200. PubMed ID: 37599139
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic Malignant Syndrome.
Pileggi DJ; Cook AM
Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
[TBL] [Abstract][Full Text] [Related]
20. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.
Belvederi Murri M; Guaglianone A; Bugliani M; Calcagno P; Respino M; Serafini G; Innamorati M; Pompili M; Amore M
Drugs R D; 2015 Mar; 15(1):45-62. PubMed ID: 25578944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
